Predictive Oncology Inc. — Director's Dealing 2012

Apr 24, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2011-12-28

Reporting Person: Herschkowitz Samuel (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-21	Common Stock, par value $0.01 per share	J	7500000	—	Acquired	13967385	Direct

Footnotes

F1: Pursuant to the Amended and Restated Note Purchase Agreement, dated as of December 20, 2011, by and among the Issuer and Dr. Samuel Herschkowitz (the "First Note Purchase Agreement"), in exchange for a loan in cash in the amount of $240,000 from Dr. Herschkowitz to the Issuer, the Issuer issued to Dr. Herschkowitz a Convertible Promissory Note (the "First Note"), dated December 20, 2011, in the principal amount of $240,000. Pursuant to the First Note Purchase Agreement, upon the occurrence of an event of default under the First Note, the Issuer is required to issue 7,500,000 shares to Dr. Herschkowitz as a penalty. On April 21, 2012, Dr. Herschkowitz sent a letter to the Issuer notifying the Issuer of several events of default under the First Note. Dr. Herschkowitz has in his possession a stock certificate evidencing 7,500,000 shares registered in his name.